Business Wire

ByteDance Purchases more than 100,000 Units of Rubicon Carbon’s Flagship Product, The Rubicon Carbon Tonne ®

25.6.2025 15:00:00 EEST | Business Wire | Press release

Share

Rubicon Carbon, a leading carbon credit management firm, announced today that ByteDance, the global technology company behind content platforms including TikTok, has purchased the right to retire more than 100,000 tonnes of carbon credits. The credits were purchased through Rubicon Carbon’s flagship carbon credit offering, the Rubicon Carbon Tonne® (RCT), and represent a milestone on ByteDance’s path toward achieving its carbon neutrality target by 2030 while also underscoring the company’s commitment to high-integrity climate action.

Rubicon Carbon Tonnes (RCTs) are actively managed portfolios of high-quality carbon credits from global projects, including nature-based, super pollutant, and carbon removal initiatives. Rubicon’s science team ensures ongoing monitoring and integrity. Buyers secure access to premium credits at today’s prices, reducing exposure to future cost spikes and supply issues. With expert management, RCTs offer confidence that retired credits will meet the highest standards and deliver measurable climate impact.

The RCTs acquired by ByteDance include a carefully curated mix of nature-based avoidance credits and carbon removal credits designed to deliver both immediate climate impact and long-term carbon dioxide removal.

“We are thrilled to welcome ByteDance as a buyer of Rubicon Carbon Tonnes,” said Tom Montag, CEO of Rubicon Carbon. “ByteDance’s decision to invest in RCTs signals a serious, long-term commitment to climate leadership and a recognition that the path to net zero must be built on high-quality, durable carbon solutions. We're proud to play a role in helping them meet that goal.”

To achieve its carbon neutrality goals by 2030, ByteDance aims to reduce at least 90% of its operational emissions, with the remaining 10% offset by carbon credits. Rubicon Carbon’s team provided ByteDance with robust educational resources and advisory support, helping the company evaluate its purchases in the voluntary carbon market with confidence.

“We greatly appreciate the time and expertise that the Rubicon Carbon team invested to help us make high-value and impactful decisions within the carbon credit landscape,” said Ian Gill, Global Head of Sustainability at ByteDance. “As we advance toward our 2030 carbon neutrality goal, it’s critical that we build long-term relationships with trusted partners. This purchase marks an important step in that journey, and we look forward to continuing our collaboration with Rubicon Carbon.”

The announcement builds on Rubicon Carbon’s continued momentum as a trusted partner to global organizations seeking scalable, science-based climate solutions. The company’s unique approach to carbon credit sourcing — combining rigorous project selection with a portfolio-based structure — ensures that every Rubicon Carbon Tonne meets the highest standards of environmental integrity.

For more information about Rubicon Carbon and the Rubicon Carbon Tonne, visit rubiconcarbon.com.

About Rubicon Carbon:
Rubicon Carbon is a carbon credit management firm that empowers the world’s largest enterprises to achieve their sustainability goals by addressing carbon emissions and driving global climate finance. Backed by TPG Rise Climate and led by top executives from across finance, technology, and climate science, Rubicon Carbon delivers innovative carbon credit solutions to global businesses while unlocking carbon avoidance and removal projects at scale, all backed by rigorous in-house scientific diligence. For more information, visit www.rubiconcarbon.com.

About ByteDance:
Founded in 2012, ByteDance's mission is to inspire creativity and enrich life. With a suite of more than a dozen products, including TikTok, Helo, and Resso, as well as platforms specific to the Chinese market, including Toutiao, Douyin, and Xigua, ByteDance has made it easier and more fun for people to connect with, consume, and create content. ByteDance's investors include Coatue, General Atlantic, KKR, Sequoia Capital, SIG, and Softbank.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250625148017/en/

Contacts

Rubicon Carbon Media Relations
rubiconcarbon@berlinrosen.com
+1 (714) 300-8748

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Strongest Half-Year in Curatis’s History — Revenue up 51% and Significant Progress on Corticorelin (C-PTBE-01)21.9.2026 08:03:00 EEST | Press release

Curatis Holding AG (SIX:CURN, “Curatis”) reports net sales from goods and services of CHF 7.9m for the first half of 2026, up 51% (H1 2025: CHF 5.2m), with the loss for the period narrowing to CHF -0.4m (H1 2025: CHF -1.2m) and cash and cash equivalents rising to CHF 3.6m (31 December 2025: CHF 1.9m). Curatis also advanced its corticorelin (C-PTBE-01) program on multiple levels, including an exclusive Japan licence with Neupharma and continued manufacturing progress. Business development and finances Net sales from goods increased by 46% to CHF 7.4m (H1 2025: CHF 5.0m) and net sales from services rose to CHF 0.6m (H1 2025: CHF 0.2m). Growth was driven both by products marketed for some time and by products added to the distribution portfolio in 2025 and 2026. The gross contribution from goods and services rose by 32% to CHF 1.8m (H1 2025: CHF 1.3m); the combined cost base grew by only 9% against net sales growth of 51%, as personnel expenses rose 5% to CHF 1.3m (H1 2025: CHF 1.2m) and

Galderma Begins Trading in the Swiss Market Index, Joining Switzerland's Leading Blue Chip Companies21.9.2026 08:00:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today begins trading as a constituent of the Swiss Market Index (SMI), Switzerland's leading blue chip equity benchmark comprising 20 of the country's largest and most liquid listed companies. Less than three years after its IPO on the SIX Swiss Exchange in March 2024, Galderma has established itself as one of Switzerland's leading listed companies. Its inclusion in the SMI reflects the company's strong growth, disciplined execution and increasing relevance in Swiss and international capital markets as it advances its ambition to become the world's leading dermatology powerhouse. Since its IPO, Galderma has continued to execute its growth-focused integrated dermatology strategy, delivering strong performance across Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Net sales increased from 4.410 billion USD in 2024 to 5.207 billion USD in 2025, driven by science-led innovation, portfolio and geogr

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye